Xenia Hotels & Resorts (XHR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Q2 2025 net income rose to $55.2M, up over 259% year-over-year, driven by a $40M gain on the Fairmont Dallas sale and strong group and catering revenues, especially at Grand Hyatt Scottsdale Resort.
Adjusted EBITDAre for Q2 was $79.5M, up 16.3% year-over-year, with significant increases in hotel EBITDA and margin, supported by robust group business.
Portfolio RevPAR increased 4% to $195.51, with occupancy at 72.3% and ADR at $270.42, reflecting a balanced demand mix.
Sale of Fairmont Dallas for $111M generated an 11.3% unlevered IRR and $40M gain, optimizing capital allocation.
Share repurchases totaled nearly 6M shares YTD for $71.5M, with $146M remaining under authorization.
Financial highlights
Q2 total revenues were $287.6M, up 5.4% year-over-year; six-month revenues reached $576.5M, up 6.7%.
Q2 adjusted FFO per share was $0.57, up 9.6% year-over-year; Q2 same-property hotel EBITDA was $84M, up 22.2%.
Q2 same-property hotel EBITDA margin was 29.4%, up 269 bps; same-property RevPAR up 4% to $195.51.
Food and beverage revenues rose 14.7%–20.9% year-over-year in Q2.
Gain on sale of Fairmont Dallas contributed $40M to Q2 results.
Outlook and guidance
Full-year 2025 adjusted EBITDAre guidance raised to $249M–$263M; adjusted FFO to $166M–$180M; net income guidance $58M–$72M.
Full-year RevPAR growth guidance at 3.5%–5.5%; excluding Scottsdale, expected at 1.5%.
Capital expenditures for 2025 projected at $75M–$85M, down $25M from initial projection.
Group room revenue pace for H2 up 16% (7% ex-Scottsdale); 2026 group pace up mid-teens percent.
Management remains focused on maximizing revenue, profits, and sustainable cash flow amid macroeconomic headwinds.
Latest events from Xenia Hotels & Resorts
- Double-digit earnings growth in 2025 with strong demand; 2026 outlook remains positive.XHR
Q4 202514 Mar 2026 - Net income up, EBITDAre down, and guidance trimmed as renovations and expense pressures persist.XHR
Q2 20242 Feb 2026 - Q3 loss and margin pressure offset by occupancy gains, strong group demand, and project completions.XHR
Q3 202415 Jan 2026 - 2025 guidance projects 3.5–6.5% RevPAR growth and $244–$264M Adjusted EBITDAre.XHR
Q4 202423 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and strong governance.XHR
Proxy Filing2 Dec 2025 - Board recommends approval of all proposals, including director elections and plan amendment.XHR
Proxy Filing2 Dec 2025 - Board seeks approval to expand equity awards, reinforcing pay-for-performance alignment.XHR
Proxy Filing2 Dec 2025 - Q1 2025 net income and RevPAR surged, but guidance was trimmed amid macro uncertainty.XHR
Q1 202528 Nov 2025 - Year-to-date net income and EBITDAre rose despite a Q3 net loss and flat RevPAR.XHR
Q3 20252 Nov 2025